okredo logo
none title certification

UAB "Droplet Genomics" Finance - revenue, profit

eye icon
More information

EBITDA margin (%)

unlock data icon

Register and

explore Okredo data
More information

EBIT margin (%)

unlock data icon

Register and

explore Okredo data

EBITDA margin (%)

Login to see the data

EBIT margin (%)

Login to see the data

Financial statetment report

Price: €9.90
Premium users: 1.00 credit
Indicator
Turnover (€)
Sales per employee (€)info
Profit before tax (€)
Net Profit (€)
Profit per employee (€)info
Working capital requirementinfo
Debt-to-equity ratioinfo
Total profitability (%)info
Net profitability (%)info
Equity (€)
Amounts Payable And Liabilities (€)
Non-current Assets (€)
CurrentAssets (€)
EBITDA margin (%)info
EBITDA (€)info
EBIT margin (%)info
EBIT (€)info
2021
870,777
42,539
57,870
57,870
2,827
0.81
-6.58
78.84
6.65
-178,748
1,176,255
214,146
834,640
2022
1,931,408
66,212
-34,810
-34,810
-1,193
0.26
4.77
80.99
-1.80
878,566
4,193,960
381,529
4,705,688
2023
2,845,771
56,632
-1,429,854
-1,429,854
-28,455
1.11
0.08
81.32
-50.24
3,628,287
289,738
449,032
3,596,593
unlock data icon

Register and

explore Okredo data
2023
2,845,771
56,632
-1,429,854
-1,429,854
-28,455
1.11
0.08
81.32
-50.24
3,628,287
289,738
449,032
3,596,593
unlock data icon

Register and

explore Okredo data

2023

Turnover (€)

2,845,771 €Ascended47 % *

Sales per employee (€)

56,632 €Descended-14 % *

Profit before tax (€)

-1,429,854 €Descended-4,008 % *

Net Profit (€)

-1,429,854 €Descended-4,008 % *

Profit per employee (€)

-28,455 €Descended-2,285 % *

Working capital requirement

1.11 Ascended326.92 % *

Debt-to-equity ratio

0.08 Descended-98.32 % *

Total profitability (%)

81.32 %Ascended0.41 % *

Net profitability (%)

-50.24 %Descended-2,691.11 % *

Equity (€)

3,628,287 €Ascended313 % *

Amounts Payable And Liabilities (€)

289,738 €Descended-93 % *

Non-current Assets (€)

449,032 €Ascended18 % *

CurrentAssets (€)

3,596,593 €Descended-24 % *

*over the last year starting selected period